Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 69,000 people in 80 offices around the world, and market our products in 170 countries. Our focus is on the serious chronic diseases that affect hundreds of millions of people and are among the most urgent global health challenges. By combining our innovation and commercial excellence, we draw upon insights from patients and partners to transform bold ideas into life-saving and preventive medicines. We have marketed products to treat type 1 diabetes, type 2 diabetes, obesity, haemophilia, and growth disorders.
Our Graduate Programme
Based in Athlone, our graduate programme is 2 years in duration and offers a great opportunity to put what you have learned through your undergraduate into practice and carve the path to your future career. Our programme focuses on rotating through different departments in Novo Nordisk, getting hands on experience and exposure to many different facets of our manufacturing and R&D site. Some of the rotations include Engineering, Information Technology, Manufacturing, Quality Assurance, Validation, Regulatory Supply Chain. We offers excellent opportunities for career development in an environment that is science-driven, intellectual, inclusive and collaborative. Participants in the programme are eligible to receive a competitive salary, healthcare, pension and other benefits.
Your learning journey continues with a variety of training and development programs on your personal brand, communication, people management and technical courses which lends to our culture of continuous learning, empowering individuals to drive their own growth and development. This programme utilises a blended learning approach.